Literature DB >> 28502847

The Role for Cardiologists in Stroke Intervention.

Richard R Heuser1.   

Abstract

Even though cardiovascular disease (CVD) is still the leading cause of death in the United States, stroke is the second leading global cause of death behind CVD. In the 21st Century, less than 40% of overall stroke patients are discharged to home and almost 25% of Medicare beneficiaries do not survive 90 days. In spite of the fact that tissue plasminogen activator (TPA) has been approved for stroke care for 20 years, only .75% of annual strokes are actually treated with intravenous (IV) TPA. Similar to how interventional cardiologists evolved from IV to catheter mechanical treatment for acute myocardial infarctions (AMI) over 30 years ago, over the last few years, neurointerventionists now perform endovascular stroke therapy in many of these patients using stent retrievers. However, very few stroke patients are actually getting treatment, and neurointerventionists on an average perform only 8 stroke interventions per year. It has been recently shown that 9 out of 10 strokes can be prevented by controlling CVD risk factors. A principal job for cardiologists is to recognize and manage these CVD risk factors in addition to being involved with performing intervention. Atrial Fibrillation is certainly a common problem in all of our practices and puts people at five-fold higher risk of stroke. Cardiovascular cardiology teams already have 24/7 coverage for acute interventions for AMI in place at their facilities. A number of groups have replicated acute stroke care performed by cardiologists at centers worldwide with outstanding results. It makes sense that we try to build a collaboration among neuroradiologists, interventional cardiologists and perhaps vascular or neurosurgeons with expertise in acute endovascular procedures to develop programs for acute and active 24/7 stroke care similar to systems for primary angioplasty for AMI.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute ischemic stroke; Cardiology; Endovascular stroke therapy

Mesh:

Year:  2017        PMID: 28502847     DOI: 10.1016/j.pcad.2017.05.002

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  5 in total

1.  Targeted delivery of fat extract by platelet membrane-cloaked nanocarriers for the treatment of ischemic stroke.

Authors:  Cheng Wang; Xuewei Yang; Yixu Jiang; Lin Qi; Deli Zhuge; Tongtong Xu; Yiyan Guo; Mingwu Deng; Wenjie Zhang; Dongyan Tian; Qingqing Yin; Li Li; Zhijun Zhang; Yongting Wang; Guo-Yuan Yang; Yijie Chen; Yaohui Tang
Journal:  J Nanobiotechnology       Date:  2022-05-31       Impact factor: 9.429

2.  The short- and long-term efficacies of endovascular interventions for the treatment of acute ischemic stroke patients.

Authors:  Xingxiu Yang; Xiaohui Jia; Hua Ren; Hongxing Zhang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  Tuina plus acupuncture for post-stroke depression: A protocol for systematic review and meta-analysis.

Authors:  Meng Meng; Guanyu Hu; Kang Yang; Heran Wang; Yiran Han; Ting Pan; Huijuan Lou; Ye Zhang; Yufeng Wang; Deyu Cong
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

4.  RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery.

Authors:  Rubin Hao; Bixi Sun; Lihua Yang; Chun Ma; Shuling Li
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

5.  Identification of potential diagnostic biomarkers of cerebral infarction using gas chromatography-mass spectrometry and chemometrics.

Authors:  Ming-Jiao Li; Hong Xiao; Yi-Xing Qiu; Jian-Hua Huang; Rong-Yong Man; Yan Qin; Guang-Hua Xiong; Qing-Hua Peng; Yu-Qing Jian; Cai-Yun Peng; Wei-Ning Zhang; Wei Wang
Journal:  RSC Adv       Date:  2018-06-21       Impact factor: 4.036

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.